Cell-Free DNA BCT

Cell-Free DNA BCT is an FDA 510(k)-cleared medical device (K231776) manufactured by Streck, Inc.. This device is classified under the Clinical Chemistry specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on July 25, 2024. Regulation: 8.